This continuing medical education course will provide a multidisciplinary update in the prevention, evaluation, diagnosis, management, and treatment of benign and malignant breast diseases, high risk, and survivorship issues. The course has multidisciplinary experts in their field presenting the latest diagnostic, treatment, and management options.
•Updates in genetic testing, novel radiology modalities, and integrative medicine.
•Discussion of controversies in breast and axillary surgery approaches, current status of neoadjuvant chemotherapy,
and the influence of neoadjuvant therapy choices on surgical decision making.
MD, DO, Ph.D. : USD 595.0
Resident, Fellow, NP, PA, Allied Health Professional: USD 495.0
Speakers: Sarah A. McLaughlin, M.D., , Barbara A. Pockaj, M.D., Sandhya Pruthi, M.D., Amy Degnim, MD, Celine Vachon, PhD, Juliana Kling, MD, MPH, Elizabeth Gilman, MD, Sarah Macklin, MS, CGC, Lauren Cornell, MD, Aziza Nassar, MD, Robert Fazzio, MD, PhD, Emmanuel Gabriel, MD, PhD, Robert Maxwell, MD, James Jakub, MD, Brian Rinker, MD, Brenda Ernst, MD, Pooja Advani, MBBS, Jessica Jackson, MS, CGC, Katherine Tzou, MD, Jacqueline Thielen, MD, Dawn Mussallem, DO, Adam Perlman, MD, Saranya Chumsri, MD, Antonio J. Forte, MD, PhD, MS, Olivia Ho, MD, MMSc, FRCSC